within Pharmacolibrary.Drugs.N_NervousSystem.N05A_Antipsychotics.N05AL07_Levosulpiride;

model Levosulpiride
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.3,
    Cl = 2.3333333333333336e-06,
    adminDuration = 600,
    adminMass = 25 / 1000000,
    adminCount = 1,
    Vd = 0.0014,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.012583333333333334,
    Tlag = 10.200000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Levosulpiride</td></tr><tr><td>ATC code:</td><td>N05AL07</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>25</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1.4</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.12</td><td>L/hr/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Levosulpiride is a substituted benzamide antipsychotic and prokinetic agent that acts as a selective dopamine D2 receptor antagonist. It is used primarily in the treatment of psychiatric disorders such as schizophrenia, depression, and somatoform disorders, as well as gastrointestinal motility disorders like dyspepsia and gastroparesis. While it is not approved in the United States, it is used in several countries including India and Italy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following a single oral 25 mg dose.</p><h4>References</h4><ol><li><p>Xu, M, et al., &amp; Li, W (2015). Tolerability and Pharmacokinetic Comparison of Oral, Intramuscular, and Intravenous Administration of Levosulpiride After Single and Multiple Dosing in Healthy Chinese Volunteers. <i>Clinical therapeutics</i> 37(11) 2458–2467. DOI:<a href=\"https://doi.org/10.1016/j.clinthera.2015.08.024\">10.1016/j.clinthera.2015.08.024</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26404395/\">https://pubmed.ncbi.nlm.nih.gov/26404395</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N05AL07 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Levosulpiride;
